Polydex Pharmaceuticals Ltd (OTCMKTS:POLXF) shares crossed below its 50-day moving average during trading on Wednesday . The stock has a 50-day moving average of $1.07 and traded as low as $1.03. Polydex Pharmaceuticals shares last traded at $1.06, with a volume of 2,900 shares trading hands.

The firm has a market capitalization of $3.63 million, a price-to-earnings ratio of 10.60 and a beta of -0.33. The business’s 50-day simple moving average is $1.07 and its two-hundred day simple moving average is $0.99. The company has a quick ratio of 2.90, a current ratio of 4.10 and a debt-to-equity ratio of 0.04.

Polydex Pharmaceuticals (OTCMKTS:POLXF) last announced its quarterly earnings results on Monday, June 17th. The company reported $0.06 earnings per share for the quarter. Polydex Pharmaceuticals had a net margin of 6.89% and a return on equity of 5.69%. The business had revenue of $1.22 million during the quarter.

Polydex Pharmaceuticals Company Profile (OTCMKTS:POLXF)

Polydex Pharmaceuticals Limited, through its subsidiaries, manufactures bulk pharmaceutical intermediates for the veterinary pharmaceutical industry worldwide. It also develops, manufactures, and markets biotechnology-based products for the human pharmaceutical market. The company primarily offers dextran and derivative products, including Iron Dextran, a derivative of dextran that is injected into pigs at birth as a treatment for anemia; and dextran sulphate, a specialty chemical derivative of dextran used in biotechnology applications and the pharmaceutical industry.

Featured Story: Why do companies pay special dividends?

Receive News & Ratings for Polydex Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Polydex Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.